BOK Financial’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $454 | Buy |
+2
| New | +$356 | ﹤0.01% | 1139 |
|
|
2026
Q1 | – | Sell |
-129
| Closed | -$25.7K | – | 1050 |
|
|
2025
Q4 | $25.7K | Sell |
129
-18
| -12% | -$3.27K | ﹤0.01% | 907 |
|
|
2025
Q3 | $23K | Buy |
147
+143
| +3,575% | +$22.7K | ﹤0.01% | 930 |
|
|
2025
Q2 | $607 | Sell |
4
-3,324
| -100% | -$443K | ﹤0.01% | 1107 |
|
|
2025
Q1 | $501K | Sell |
3,328
-2,224
| -40% | -$373K | 0.01% | 558 |
|
|
2024
Q4 | $1.03M | Sell |
5,552
-508
| -8% | -$97.9K | 0.02% | 436 |
|
|
2024
Q3 | $1.15M | Buy |
6,060
+59
| +1% | +$12.3K | 0.02% | 422 |
|
|
2024
Q2 | $1.24M | Sell |
6,001
-30
| -0.5% | -$6.8K | 0.02% | 437 |
|
|
2024
Q1 | $1.62M | Buy |
6,031
+575
| +11% | +$137K | 0.03% | 404 |
|
|
2023
Q4 | $1.29M | Sell |
5,456
-452
| -8% | -$88.9K | 0.03% | 421 |
|
|
2023
Q3 | $995K | Sell |
5,908
-139
| -2% | -$28.5K | 0.02% | 439 |
|
|
2023
Q2 | $1.27M | Buy |
6,047
+54
| +0.9% | +$10.7K | 0.03% | 419 |
|
|
2023
Q1 | $1.21M | Sell |
5,993
-254
| -4% | -$57.6K | 0.03% | 429 |
|
|
2022
Q4 | $1.36M | Buy |
6,247
+159
| +3% | +$34.7K | 0.03% | 442 |
|
|
2022
Q3 | $1.2M | Sell |
6,088
-254
| -4% | -$54.8K | 0.02% | 466 |
|
|
2022
Q2 | $1.36M | Buy |
6,342
+2,782
| +78% | +$680K | 0.03% | 453 |
|
|
2022
Q1 | $1.01M | Sell |
3,560
-55
| -2% | -$17K | 0.02% | 567 |
|
|
2021
Q4 | $1.36M | Buy |
3,615
+68
| +2% | +$26.4K | 0.02% | 496 |
|
|
2021
Q3 | $1.46M | Buy |
+3,547
| New | +$1.47M | 0.03% | 474 |
|
|
2021
Q1 | $1.05M | Sell |
3,620
-790
| -18% | -$220K | 0.02% | 535 |
|
|
2020
Q4 | $1.1M | Sell |
4,410
-3,256
| -42% | -$775K | 0.02% | 490 |
|
|
2020
Q3 | $1.74M | Sell |
7,666
-1,806
| -19% | -$375K | 0.04% | 351 |
|
|
2020
Q2 | $1.65M | Buy |
9,472
+43
| +0.5% | +$6.86K | 0.04% | 369 |
|
|
2020
Q1 | $1.19M | Buy |
9,429
+1,185
| +14% | +$178K | 0.03% | 388 |
|
|
2019
Q4 | $1.26M | Sell |
8,244
-4,188
| -34% | -$580K | 0.03% | 457 |
|
|
2019
Q3 | $1.65M | Sell |
12,432
-3,006
| -19% | -$403K | 0.04% | 391 |
|
|
2019
Q2 | $2.19M | Sell |
15,438
-367
| -2% | -$49.8K | 0.05% | 327 |
|
|
2019
Q1 | $2.3M | Sell |
15,805
-158
| -1% | -$20.8K | 0.06% | 321 |
|
|
2018
Q4 | $1.81M | Sell |
15,963
-5,177
| -24% | -$648K | 0.05% | 340 |
|
|
2018
Q3 | $2.84M | Sell |
21,140
-4,031
| -16% | -$498K | 0.07% | 302 |
|
|
2018
Q2 | $2.83M | Buy |
25,171
+3,904
| +18% | +$422K | 0.08% | 300 |
|
|
2018
Q1 | $2.27M | Buy |
21,267
+379
| +2% | +$40.9K | 0.06% | 326 |
|
|
2017
Q4 | $2.29M | Buy |
20,888
+30
| +0.1% | +$3.27K | 0.06% | 326 |
|
|
2017
Q3 | $2.25M | Sell |
20,858
-553
| -3% | -$56.8K | 0.07% | 317 |
|
|
2017
Q2 | $2.17M | Sell |
21,411
-104
| -0.5% | -$9.57K | 0.07% | 297 |
|
|
2017
Q1 | $1.94M | Buy |
21,515
+1,365
| +7% | +$116K | 0.06% | 322 |
|
|
2016
Q4 | $1.54M | Sell |
20,150
-246
| -1% | -$18.7K | 0.05% | 364 |
|
|
2016
Q3 | $1.7M | Sell |
20,396
-1,864
| -8% | -$156K | 0.06% | 360 |
|
|
2016
Q2 | $1.84M | Buy |
22,260
+447
| +2% | +$36.8K | 0.06% | 317 |
|
|
2016
Q1 | $1.66M | Sell |
21,813
-1,366
| -6% | -$101K | 0.06% | 326 |
|
|
2015
Q4 | $1.86M | Buy |
23,179
+10,691
| +86% | +$771K | 0.07% | 318 |
|
|
2015
Q3 | $794K | Buy |
12,488
+1,619
| +15% | +$116K | 0.03% | 468 |
|
|
2015
Q2 | $764K | Sell |
10,869
-18
| -0.2% | -$1.33K | 0.03% | 508 |
|
|
2015
Q1 | $864K | Buy |
10,887
+5,033
| +86% | +$371K | 0.03% | 462 |
|
|
2014
Q4 | $373K | Sell |
5,854
-4,017
| -41% | -$252K | 0.01% | 535 |
|
|
2014
Q3 | $589K | Sell |
9,871
-403
| -4% | -$23.1K | 0.02% | 544 |
|
|
2014
Q2 | $550K | Buy |
10,274
+29
| +0.3% | +$1.59K | 0.02% | 592 |
|
|
2014
Q1 | $618K | Sell |
10,245
-106
| -1% | -$6.18K | 0.02% | 566 |
|
|
2013
Q4 | $549K | Buy |
+10,351
| New | +$520K | 0.02% | 593 |
|
|
2013
Q3 | – | Sell |
-12,976
| Closed | -$533K | – | 818 |
|
|
2013
Q2 | $533K | Buy |
+12,976
| New | +$556K | 0.02% | 515 |
|
Other funds holding CRL
AI
BOK Financial's CRL Position: Q2 2026 in Review
BOK Financial opened a new position in Charles River Laboratories (CRL) in Q2 2026: 2 shares worth $454. The stake represents ﹤0.01% of the portfolio and ranks #1139 among its holdings. This is a return to the name: BOK Financial previously reported a position in CRL as recently as Q4 2025.
BOK Financial first reported a position in CRL in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.84M in Q3 2018. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- BOK Financial held 2 shares of Charles River Laboratories worth $454 as of Q2 2026.
- Charles River Laboratories was a new BOK Financial position in Q2 2026.
- Charles River Laboratories made up ﹤0.01% of BOK Financial's portfolio in Q2 2026, its #1139 holding.
- BOK Financial first reported a position in Charles River Laboratories in Q2 2013 and has held it in 50 quarters since.
- BOK Financial's Charles River Laboratories position peaked at $2.84M in Q3 2018.
- 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.